INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1468153601-regulation-honeycomb-hand-target]( "Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals")
Understanding Decentralized Clinical Trials: FDA vs. EMA FundamentalsDesigning a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.
-
![Group of doctors in meeting-GettyImages-2169868459]( "What Controlled Immune Challenges Reveal Before Patient Studies Begin")
What Controlled Immune Challenges Reveal Before Patient Studies BeginControlled immune challenges can reveal target engagement and pharmacology before efficacy is measurable, supporting earlier and more informed development decisions.
-
![GettyImages-2190243697-modern-lab-researching]( "Rapid Expansion Of Peptide And Nanobody Drug Conjugates")
Rapid Expansion Of Peptide And Nanobody Drug ConjugatesPeptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
-
![GettyImages-1319939893-car-travel-road]( "Recruitment To Screening: Bridging The Gap")
Recruitment To Screening: Bridging The GapExplore how providing tracked transportation for patients can streamline recruitment, improve site conversion rates, and deliver measurable ROI for clinical trials.
-
Automation Testing In RTSM Software: What Is It And What's The Impact2/25/2026
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
How Pharmacometrics Informs Dose Selection And Biomarker Decisions6/10/2026
Quantitative modeling guides early dose and biomarker insights, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
-
How To Accelerate Early-Phase Oncology Trial5/12/2026
Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
Sustaining Participation In A 20-Year Alzheimer's Family Study8/14/2026
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Milestone-concept-GettyImages-871890160]( "RTSM Solutions That Adapt To Your Needs")
At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.
-
![Cloud computing digita-GettyImages-2161057424]( "Unify Workflows And Accelerate Execution From Protocol To Submission")
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
-
![Brain]( "Trialtrove: The Most Trusted, Comprehensive & Reliable Clinical Trial Intelligence")
Trialtrove is the industry's go-to resource to support and inform clinical trial strategy, design and execution. Our expert analysts provide insights into trial timing benchmarks, enrollment successes and failures, accrual details and study results.
-
![Eye Drop iStock-1182318206]( "Comprehensive Services For Ophthalmology Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "Drug Development Experience For Biotechs")
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
